PROCEPT BioRobotics (PRCT) Gross Profit (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Gross Profit for 7 consecutive years, with $62.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Gross Profit rose 20.55% year-over-year to $62.4 million in Q2 2026; TTM through Jun 2026 was $216.6 million, a 22.75% increase from a year earlier, with the FY2025 full-year figure at $196.2 million, up 43.13% from the prior year.
• Gross Profit was $62.4 million for Q2 2026 at PROCEPT BioRobotics, up from $53.9 million in the prior quarter.
• Over five years, Gross Profit peaked at $62.4 million in Q2 2026 and troughed at $7.7 million in Q1 2022.
• A 5-year average of $31.0 million and a median of $28.3 million in 2024 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit jumped 141.3% in 2022 and grew 6.05% in 2025, its largest moves.
• Over 5 years, Gross Profit stood at $10.7 million in 2022, then surged by 99.09% to $21.3 million in 2023, then soared by 105.47% to $43.7 million in 2024, then grew by 6.05% to $46.3 million in 2025, then soared by 34.69% to $62.4 million in 2026.
• The last three Gross Profit figures came in at $62.4 million (Q2 2026), $53.9 million (Q1 2026), and $46.3 million (Q4 2025), per Business Quant data.